AI

#AI #Digital therapeutics #Immunotherapy #Investment

This week in drug discovery (23-27 May) 

News round-up by DDW’s Reece Armstrong for 23-27 May   UK investment plans, company appointments to drive strategy, and digital health platforms are some of the themes of this week’s news round-up.    New £20m fund launches to support North West life sciences  A new £20… Read More

#News

#AI #Protein chemistry / Proteomics

Benchling launches beta for biomolecule design  

R&D cloud platform provider Benchling has launched a new artificial intelligence (AI) programme to help scientists predict 3D structures of novel proteins.    The company has launched a beta version of its AlphaFold programme – an AI platform developed by DeepMind that can predict the 3D structure… Read More

#News

#AI #Drug development #Drug discovery

Iktos teams up with Sygnature Discovery on development project  

Artificial intelligence company Iktos has announced a collaboration with drug discovery company Sygnature Discovery in a deal designed to accelerate drug discovery and development.  The three-year deal will see Sygnature using Iktos’ de novogenerative design software Makya to facilitate rapid and efficient design of novel… Read More

#News

#AI #Data #Drug discovery

BenevolentAI achieves third milestone with AstraZeneca

AstraZeneca has identified an additional target for its idiopathic pulmonary fibrosis (IPF) pipeline using an AI system designed by drug discovery company BenevolentAI. It is now the third target from that collaboration that has been identified using BenevolentAI’s platform. AstraZeneca is using the company’s Benevolent Platform across two disease areas… Read More

#News

#AI #Data science #Microbiome

Exploiting the microbiome to drive nature – inspired innovation

Listen to this article on the DDW Podcast: Exploitation of microbiome science will unlock multiple commercial opportunities across a number of industries including life sciences. But there is a need for more effective data and process management to get the best from microbiome data, according to Dr Sven Sewitz, Director of… Read More

#Exclusive Content

#AI #Biologics / Biotechnology #Lab automation #SLAS Europe

Using imagination and innovation to bring the scientific world together

Ahead of SLAS Europe May 24-27, 2022, in Dublin, Jill Hronek, SLAS Director, Marketing & Communications, shares how the SLAS community responded to the unprecedented need for laboratory automation internationally, and reflects on the conference theme, ‘Where Imagination Inspires Innovation’. Welcome back to the SLAS Europe Conference and Exhibition; it… Read More

#Exclusive Content

#AI #Biotechnology #Clinical trials #mRNA

Talking tech in 2022

Listen to this article on the DDW Podcast: With Covid-19 taking so much of the drug discovery and development’s focus over the last two years, it has been easy to overlook other areas within the sector that deserve our attention. With Q1 on its way out, Lu Rahman highlights the technology… Read More

#Exclusive Content

#AI #Drug discovery

DNDi and BenevolentAI to tackle dengue in drug discovery project  

Artificial intelligence (AI) company BenevolentAI and not-for-profit R&D organisation Drugs for Neglected Disease initiative (DNDi) have launched a joint research project to tackle dengue, one of the world’s most prevalent infectious diseases.  Dengue represents one of the top 10 threats to global public health worldwide. Despite an… Read More

#News

#AI #Drug discovery #Small molecules

X-Chem launches small molecule discovery platform

Artificial intelligence (AI) company X-Chem has announced that its drug discovery platform XD3 is now available to biopharma partners and clients. XD3 is the company’s small molecule drug discovery platform and combines data generated through DNA-encoded library (DEL) screening, along with analytical and predictive capabilities offered by A-Chem’s AI platform,… Read More

#News

#AI #Business Intelligence Group #Drug discovery

X-Chem VP recognised for AI contributions  

Noor Shaker, the Senior Vice President and General Manager for DNA technology company X-Chem, has been named a winner in the Artificial Intelligence Excellence Awards programme from Business Intelligence Group.   Shaker was one of six receiving an individual award from Business Intelligence Group, which recognises people and organisations applying… Read More

#News

#AI #Biotechnology #Technology

This week in drug discovery (4-8 April) 

News round-up by DDW’s Megan Thomas for 4-8 April   When considering trends in the drug discovery industry, the use of technology to advance treatments and therapeutics is consistently observed. DDW rounds up five of this week’s top news stories which reveal this theme of technology, AI and… Read More

#News

#AI #Drug discovery

Iktos teams up with Ono Pharmaceuticals on AI project  

Artificial intelligence (AI) company Iktos has announced a collaboration with Ono Pharmaceuticals focused on expediting drug discovery for pre-clinical candidates.   The collaboration will see Iktos apply its de novo ligand and structure-based generative modelling technologies and software Makaya to complement Ono’s drug discovery capabilities. More so, Iktos… Read More

#News

#AI #Cancer

Harnessing AI to uncover new treatments for childhood brain cancer 

Dr Anton Yuryev, Professional Services Director at  Elsevier explores how a project utilising artificial intelligence is helping discover drugs for a rare type of cancer.  Artificial Intelligence (AI) has considerable potential in the life sciences and healthcare sectors, where it is increasingly contributing to R&D breakthroughs. With its capacity to reduce the… Read More

#Exclusive Content #News #Opinion

#AI #Biochemistry #Lab automation #Molecular Biology #SLAS2022

The lab of the future is now 

Listen to this article on the DDW Podcast: In the exclusive DDW & SLAS2022 supplement published ahead of SLAS2022 in Boston, US on 5-9 February, Daniel Rines, Senior Director at Strateos, shares with DDW how his role, artificial intelligence (AI), the work of Strateos and the Covid-19 pandemic have impacted the future of the lab.  Daniel Rines’ focus at Strateos is… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#AI #Drug discovery #Lab automation #SLAS2022

Perspective: education and lab automation 

Listen to this article on the DDW Podcast: Joshua Kangas, an educator in the Computational Biology Department of Carnegie Mellon University, is helping to shape the minds of future lab specialists. He tells Megan Thomas what he believes the lab of the future will look like in this exclusive DDW & SLAS2022 supplement ahead of SLAS2022… Read More

#Editor's Choice #Exclusive Content #News #Opinion